YD Bio Ltd (YDES) stock

YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 5/30

$4.88−0.32 (-6.06%)

Close on Nov 13, 2026Market cap $345.45MP/E –Yield –

YD Bio operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -883.3%, against -286.5% the year before.

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-883.3%	−596.9
FY2024	Dec 31, 2024	-286.5%	−283.6
FY2023	Dec 31, 2023	-2.8%	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is YDES.

Revenue growth16.9% · median -51.3%

Gross margin28.1% · median 46.4%

Operating margin-883.3% · median -2525.0%

Net margin-1392.6% · median -1578.8%

Advertisement
300 × 250

See a number that looks wrong?